New Zealand markets open in 2 hours 31 minutes

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.45+0.67 (+9.88%)
As of 03:29PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 899.99M
Enterprise value 202.69M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.98
Price/book (mrq)1.21
Enterprise value/revenue 5.74
Enterprise value/EBITDA -2.99

Trading information

Stock price history

Beta (5Y monthly) 1.68
52-week change 3-42.05%
S&P500 52-week change 328.04%
52-week high 313.32
52-week low 35.70
50-day moving average 37.12
200-day moving average 38.83

Share statistics

Avg vol (3-month) 31.25M
Avg vol (10-day) 31.4M
Shares outstanding 5132.74M
Implied shares outstanding 6138.55M
Float 894.54M
% held by insiders 12.14%
% held by institutions 1101.20%
Shares short (30 Apr 2024) 411.53M
Short ratio (30 Apr 2024) 49.21
Short % of float (30 Apr 2024) 411.15%
Short % of shares outstanding (30 Apr 2024) 48.68%
Shares short (prior month 28 Mar 2024) 411.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-921.30%

Management effectiveness

Return on assets (ttm)-24.58%
Return on equity (ttm)-40.40%

Income statement

Revenue (ttm)35.33M
Revenue per share (ttm)0.28
Quarterly revenue growth (yoy)4,327.90%
Gross profit (ttm)N/A
EBITDA -363.97M
Net income avi to common (ttm)-329.12M
Diluted EPS (ttm)-2.63
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)749.61M
Total cash per share (mrq)5.65
Total debt (mrq)52.31M
Total debt/equity (mrq)7.01%
Current ratio (mrq)20.73
Book value per share (mrq)5.64

Cash flow statement

Operating cash flow (ttm)-283.51M
Levered free cash flow (ttm)-171.66M